RISEDRONATE SODIUM
NDC 63304-440, RISEDRONATE SODIUM, tablet, delayed release, from Sun Pharmaceutical Industires Inc..
- Product NDC
- 63304-440
- Status
- Listed
- Labeler
- Sun Pharmaceutical Industires Inc.
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA203925
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63304-440 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RISEDRONATE SODIUM35 mg/1
Pharmacologic classes
Bisphosphonate [EPC]; Diphosphonates [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63304-440-09 | 63304044009 | 1 DOSE PACK in 1 CARTON (63304-440-09) / 4 TABLET, DELAYED RELEASE in 1 DOSE PACK (63304-440-11) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/1d9e520b-2fa6-4603-b397-f0fc24fae775
Use it
Look up 63304-440 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63304-440 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63304-440. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.